NIH Grants and Funding
Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.
NIH Staff 
Contacts and Special Interests
Release Date: May 05, 2020
Expiration Date: May 8, 2023
R01 Clinical Trial Required Participating Institutes and Centers:
- NIH Institutes and Centers that accept Investigator-Initiated R01 applications in response to the Parent R01 Clinical Trial Required Announcement - (PA-20-NNN): NHGRI, NEI, NIA, NIAAA, NIAID, NIDA, NIDCD, NIEHS, NIGMS, NIMHD, NINR, NICHD
- NIH Institutes and Centers that only accept Investigator-Initiated R01 applications proposing mechanistic clinical trials in response to the Parent R01 Clinical Trial Required Announcement (PA-20-NNN): NCCIH, NHLBI, NIAMS, NIMH, NINDS
- NIH Institutes and Centers that DO NOT ACCEPT applications in response to the Parent R01 Clinical Trial Required Announcement but ONLY accept R01 applications proposing clinical trial(s) in response to their specific funding opportunity announcements: NCI, NIBIB, IDCR, NLM, FIC, NCATS
|
NIH Institute |
Scientific/Research Contact |
Financial or Grants |
|
|
National Center for Complementary and Integrative Health (NCCIH) |
Wendy Weber, ND, PhD, MPH |
Shelley Carow |
|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
NICHD Referral Office Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Email: NICHDReferral@mail.nih.gov The NICHD supports research in areas relevant to normal and abnormal human development, including contraception, fertilization, pregnancy, childbirth, prenatal and postnatal development; childhood development through adolescence; intellectual and developmental disabilities; and rehabilitation medicine. https://www.nichd.nih.gov/grants-funding/opportunities-mechanisms/areas-research/Pages/default.aspx. Grant applications and project proposals must fall within the missions of the scientific branches of NICHD's Division of Extramural Research or its National Center for Medical Rehabilitation Research. Potential applicants are strongly encouraged to visit these pages for recent scientific advances and emerging public health topics. If you have questions about projects within a specific research area, you may find an NICHD program officer at https://www.nichd.nih.gov/grants-contracts/research-areas/priorities |
Margaret Young Grants Management Branch Telephone: 301-642-4552 Email: margaret.young@nih.gov |
|
|
Ellen Liberman, PhD |
Karen Robinson Smith |
||
|
Bettie J. Graham, Ph.D. |
Deanna L. Ingersoll |
||
|
As announced in NOT-HL-19-690, NHLBI will accept applications in response to the NIH Parent (R01 Clinical Trial Required) FOA that propose:
Please refer to NOT-HL-19-690 for additional information/clarification.
W. Keith Hoots, MD Director Division of Blood Diseases and Resources Email: hootswk@nhlbi.nih.gov Telephone: 301-435-0080 Denis Buxton, PhD Division of Cardiovascular Sciences Email: denis.buxton@nih.gov Telephone: 301-435-0515 James P. Kiley, Ph.D. Director Division of Lung Diseases Email: kileyj@nhlbi.nih.gov Telephone: 301-435-0202 George A. Mensah, MD, FACC, Director Center for Translation Research and Implementation Science (CTRIS) Email: george.mensah@nih.gov Telephone: 301-435-0422
|
Taryn Cobb |
||
|
Rene Etcheberrigaray, M.D. |
Traci Lafferty |
||
|
Division of Epidemiology and Prevention Research |
Judy Fox |
||
|
National Institute of Allergy and Infectious Diseases (NIAID) |
As announced in NOT-AI-21-037, NIAID accepts clinical trial applications submitted under PA-20-183 that are not “high-risk”. A “high-risk” clinical trial is defined by NIAID as having one or more of the following attributes:
·provision of a non-routine intervention, that is, an intervention or non-routine use of an intervention that would not otherwise be provided for the condition under study in the local facility where the study is being conducted;
·administration of an unlicensed product; or
·administration of a licensed product for an unapproved indication.
Applicants proposing “high-risk” clinical trials should not submit to this FOA. Instead applicants proposing “high-risk” clinical trials should refer to NIAID Investigator-Initiated Clinical Trial Resources. Applicants are strongly encouraged to consult the NIAID Scientific/Research Contact listed here prior to submission to confirm the appropriateness of the proposed project for this funding opportunity.
Ellen Goldmuntz, M.D., Ph.D. |
Regina Kitsoulis |
|
|
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
As announced in NOT-AR-18-008, NIAMS only accepts clinical trial applications proposing mechanistic studies for the Research Project Grant (Parent R01 Clinical Trial Required) (PA-19-055). Applicants who wish to submit clinical trial applications for consideration by NIAMS should not submit the application to this FOA. Instead, applicants must submit clinical trial applications to one of the FOAs listed at http://www.niams.nih.gov/Funding/Clinical_Research/clinical_main.asp. Applicants are strongly advised to consult with NIAMS program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity |
|
|
|
Katia Howlett, PhD National Institute on Drug Abuse (NIDA) Telephone: (301) 443-4877 Email: katia.delrahim-howlett@nih.gov |
Pam Fleming |
||
| National Institute of Biomedical Imaging and Bioengineering (NIBIB) |
Moria Bittmann, Ph.D. 301-451-4778 moria.bittmann@nih.gov |
Katie Ellis Phone: 301-451-4791 Email: kellis@mail.nih.gov |
|
|
National Institute on Deafness and Other Communication Disorders (NIDCD) |
https://www.nidcd.nih.gov/about/staff-organization/division-of-scientific-programs |
Christopher Myers |
|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Division of Diabetes, Endocrinology and Metabolic Diseases
Barbara Linder, M.D. Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Telephone: 301 594-0021 Email: linderb@mail.nih.gov Division of Kidney, Urologic and Hematologic Diseases Tracy L. Rankin, M.P.H, Ph.D. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Telephone: 301 594-4748 Email: rankint@mail.nih.gov Division of Digestive Diseases and Nutrition Aynur Unalp-Arida, M.D., Ph.D. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Telephone: 301 594-8879 Email: aynur.unalp-arida@nih.gov
NIDDK accepts applications for low risk clinical trials in its mission. Please see NOT-DK-21-004 for further information.
|
Mary K. Rosenberg
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-8891
Email: RosenbergM@extra.niddk.nih.gov |
|
|
Bonnie Joubert, Ph.D. |
Aaron Nicholas |
||
As announced in NOT-GM-22-027, NIGMS will accept applications in response applications to the NIH Parent (R01 Clinical Trial Required) FOA that propose:
Please refer to NOT-GM-22-027 for additional information. |
NIGMS supports investigator-initiated research in the following clinical research areas: |
||
|
As stated in NOT-MH-19-031, NIMH only accepts clinical trial applications proposing mechanistic studies under the Parent R01 Clinical Trial Required (PA-19-055). For consideration by the NIMH, applicants who wish to submit clinical trials that propose to test efficacy, effectiveness or safety should not submit to this FOA. Instead, clinical trials testing efficacy, effectiveness or safety must be submitted to one of the FOAs listed here: https://www.nimh.nih.gov/funding/opportunities-announcements/clinical-trials-foas/index.shtml#ctfoa. Applicants are strongly advised to consult with NIMH program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity announcement. |
Terri Jarosik |
||
|
National Institute on Minority Health and Health Disparities (NIMHD) |
The National Institute on Minority Health and Health Disparities (NIMHD) will accept investigator-initiated research projects (R01) for all program areas supported by the Institute. |
Priscilla Grant, JD |
|
|
National Institute of Neurological Disorders and Stroke (NINDS) |
Rebecca Hommer, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Phone: 301-827-2257
E-mail: Rebecca.hommer@nih.gov
As announced in NOT-NS-18-011, NINDS only accepts clinical trial applications proposing mechanistic studies for the Clinical Trial Required Parent R01 (PA-18-345). Applications that include a prospective biomedical or behavioral research study of human subjects that is designed to answer specific questions about pharmacologic, behavioral, biologic, surgical, or device interventions should be submitted to an NINDS clinical trial-specific funding announcement (listed on the NINDS website at https://www.ninds.nih.gov/Current-Research/Research-Funded-NINDS/Clinical-Research). Applicants are strongly advised to consult with NINDS program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity. |
Chief Grants Management Officer |
|
|
The National Institute of Nursing Research (NINR) will accept applications for projects in areas that are mission-relevant (http://www.ninr.nih.gov/AboutNINR/NINRMissionandStrategicPlan/). Please contact the NINR Program Director listed in the area of science in which you are interested. NINR Program Staff contacts may be found at: https://www.ninr.nih.gov/researchandfunding/desp/oep/areasofscience |
Brian Albertini |
